Market Capitalization (Millions $) |
0 |
Shares
Outstanding (Millions) |
2 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-13 |
Cash Flow (TTM) (Millions $) |
-7 |
Capital Exp. (TTM) (Millions $) |
0 |
Kintara Therapeutics Inc
Kintara Therapeutics Inc is a biopharmaceutical company that specializes in the development of novel cancer therapies. The company focuses on repurposing existing drugs and drug combinations to treat various types of cancers including glioblastoma, a deadly form of brain cancer. Kintara Therapeutics aims to improve patient outcomes by developing effective and affordable treatments. The company's approach involves conducting clinical trials to evaluate the safety and efficacy of their therapies. Kintara Therapeutics Inc strives to make a positive impact in the field of oncology by bringing innovative treatment options to patients in need.
Company Address: 9920 Pacific Heights Blvd San Diego 92121 CA
Company Phone Number: 350-4364 Stock Exchange / Ticker: NASDAQ KTRA
|